Assets in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary
Ambrx Biopharma Cayman, Inc. quarterly Assets history and change rate from Q4 2020 to Q2 2023.
  • Ambrx Biopharma Cayman, Inc. Assets for the quarter ending 30 Jun 2023 was $279,944,000.000, a 54.8% increase year-over-year.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2023 $279,944,000 +$99,074,000 +54.8% 30 Jun 2023 10-Q 09 Aug 2023
Q1 2023 $210,613,000 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $146,977,000 -$82,042,000 -35.8% 31 Dec 2022 10-Q 09 Aug 2023
Q2 2022 $180,870,000 30 Jun 2022 6-K 29 Aug 2022
Q4 2021 $229,019,000 +$94,998,000 +70.9% 31 Dec 2021 10-K 30 Mar 2023
Q4 2020 $134,021,000 31 Dec 2020 20-F 26 Apr 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.